Glycine Does Not Add to the Beneficial Effects of Perioperative Oral Immune-Enhancing Nutrition Supplements in High-Risk Cardiac Surgery Patients

Abstract

Background: Elderly patients and patients with a poor cardiac function have increased morbidity rates when undergoing cardiac surgery. The aim of this study was to determine whether addition of glycine to a standard preoperative oral immune-enhancing nutrition supplement (OIENS) improves outcome. Glycine-enriched OIENS was compared with 2 formulas: standard OIENS and control. Methods: In this double-blind, 3-armed study, patients scheduled to undergo cardiac surgery with the use of extracorporeal circulation received either the glycine-enriched OIENS (OIENS + glyc, n = 24), standard OIENS (OIENS, n = 25), or control formula (Control, n = 25) for minimally 5 preoperative days. Patients were included if they were aged 70 years or older, had a compromised left ventricular function, or were planned for mitral valve surgery. Main outcome measures were postoperative infectious morbidity, organ function, and postoperative recovery. Results: Infectious morbidity was significantly lower in both treatment groups compared with the control group (p = .02). An infection was diagnosed in 5 and 4 patients in the OIENS + glyc and OIENS groups, respectively, and in 12 control patients. Less supportive therapy was necessary to stabilize circulation in both treatment groups compared with the control group. Median length of hospital stay was 7.0, 6.5, and 8.0 days in the OIENS + glyc, OIENS, and control groups, respectively. Inflammatory responses, as measured by systemic levels of proinflammatory cytokines and surface markers on polymorphonuclear cells, were comparable for all groups. Conclusions: Preoperative OIENS reduces postoperative infectious morbidity and results in a more stable circulation; the addition of glycine does not result in any beneficial effect over standard OIENS.

Preoperative optimization of high-risk cardiac surgery patients with a standard preoperative oral immune-enhancing nutrition supplement compared with a control formula results in a reduced postoperative infectious morbidity and more stable circulation. The addition of extra glycine to the standard immune-enhancing formula did not result in further improvement.

Get full access to this article

View all access options for this article.

References

Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients: a clinical severity score [correction appears in JAMA. 1992;268: 1860]. JAMA 1992 ;267:2344– 2348.

Kress HG, Scheidewig C, Schmidt H, Silber R. Reduced incidence of postoperative infection after intravenous administration of an immunoglobulin A- and immunoglobulin M-enriched preparation in anergic patients undergoing cardiac surgery. Crit Care Med. 1999 ;27:1281– 1287.

Weimann A, Bastian L, Bischoff WE, et al. Influence of arginine, omega-3 fatty acids and nucleotide-supplemented enteral support on systemic inflammatory response syndrome and multiple organ failure in patients after severe trauma. Nutrition. 1998 ;14:165– 172.

O'Leary MJ, Coakley JH. Nutrition and immunonutrition. Br J Anaesth. 1996;77:118– 127.

Kirk SJ, Barbul A. Role of arginine in trauma, sepsis, and immunity. JPEN J Parenter Enteral Nutr. 1990 ;14(5 suppl):226S– 229S.

Engelman DT, Watanabe M, Maulik N, et al. L-arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion.Ann Thorac Surg. 1995;60:1275– 1281.

Sato H, Zhao ZQ, McGee DS, Williams MW, Hammon JW Jr, Vinten-Johansen J. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J Thorac Cardiovasc Surg. 1995;110:302– 314.

Jones SM, Thurman RG. L-arginine minimizes reperfusion injury in a low-flow, reflow model of liver perfusion. Hepatology. 1996 ;24:163– 168.

Nonami Y. The role of nitric oxide in cardiac surgery. Surg Today. 1997;27:583– 592.

10.

Daly JM, Weintraub FN, Shou J, Rosato EF, Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg. 1995 ;221:327– 338.

11.

Zhong Z, Thurman RG. A fish oil diet minimizes hepatic reperfusion injury in the low-flow, reflow liver perfusion model.Hepatology. 1995;22:929– 935.

12.

Kulkarni AD, Rudolph FB, Van Buren CT. The role of dietary sources of nucleotides in immune function: a review. J Nutr. 1994 ;124(8 suppl):1442S– 1446S.

13.

Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001 ;286:944– 953.

14.

Farreras N, Artigas V, Cardona D, Rius X, Trias M, Gonzalez JA. Effect of early postoperative enteral immunonutrition on wound healing in patients undergoing surgery for gastric cancer. Clin Nutr. 2005 ;24:55– 65.

15.

Tepaske R, Velthuis H, Oudemans-van Straaten HM, et al. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet. 2001;358:696– 701.

16.

Hall JC. Glycine. JPEN J Parenter Enteral Nutr. 1998 ;22:393– 398.

17.

Garner JS. The CDC Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1993 ;21:160– 162.

18.

Takala J, Uusaro A, Parviainen I, Ruokonen E. Lactate metabolism and regional lactate exchange after cardiac surgery. New Horizons. 1996;4:483– 492.

19.

Kaplan LJ, McPartland K, Santora TA, Trooskin SZ. Start with a subjective assessment of skin temperature to identify hypoperfusion in intensive care unit patients. J Trauma. 2001 ;50:620– 627.

20.

Christenson JT, Schmuziger M, Simonet F. Effective surgical management of high-risk coronary patients using preoperative intra-aortic balloon counterpulsation therapy. Cardiovasc Surg. 2001 ;9:383– 390.

21.

De Backer D, Creteur J, Vincent JL. Perioperative optimization and right heart catheterization: what technique in which patient? Crit Care. 2003;7:201– 202.

22.

Davies SJ, Wilson RJT. Preoperative optimization of the high-risk surgical patient. Br J Anaesth. 2004 ;93:121– 128.

23.

Flancbaum L, Ziegler DW, Choban PS. Preoperative intensive care unit admission and hemodynamic monitoring in patients scheduled for major elective noncardiac surgery: a retrospective review of 95 patients. J Cardiothorac Vasc Anesth. 1998;12:3– 9.

24.

Campbell B, Roberts M, Kerksick C, et al. Pharmacokinetics, safety, and effects on exercise performance of l-arginine alpha-ketoglutarate in trained adult men. Nutrition. 2006 ;22:872– 881.

25.

Zhong Z, Wheeler MD, Li X, et al. L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent. Curr Opin Clin Nutr Metab Care. 2003;6:229– 240.

26.

Beale RJ, Schneider H, Sorensen F, Smithies MN, Bennet ED, Bihari DJ. A multicentre randomised, controlled trial comparing enteral feeding with IMPACT versus IMPACT with glycine. Intensive Care Med. 2000 ;26(suppl 3):S300 .

27.

Tepaske R. Nutritional supplementation after cardiac surgery.Lancet. 2002;359:257– 258.

28.

Baldwin C, Parsons TJ. Dietary advice and nutritional supplements in the management of illness-related malnutrition: systematic review.Clin Nutr. 2004;23:1267– 1279.

29.

Macfie J, Woodcock NP, Palmer MD, Walker A, Townsend S, Mitchell CJ. Oral dietary supplements in pre- and postoperative surgical patients: a prospective and randomized clinical trial. Nutrition. 2000 ;16:723– 728.

30.

Waitzberg DL, Saito H, Plank LD, et al. Postsurgical infections are reduced with specialized nutrition support. World J Surg. 2006 ;30:1592– 1604.

31.

Kollef MH, Sharpless L, Vlasnik J, Pasque C, Murphy D, Fraser VJ. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest. 1997;112:666– 675.

32.

Rebollo MH, Bernal JM, Llorca J, Rabasa JM, Revuelta JM. Nosocomial infections in patients having cardiovascular operations: a multivariate analysis of risk factors. J Thorac Cardiovasc Surg. 1996 ;112:908– 913.

33.

Fernandez J, Chen C, Anolik G, et al. Perioperative risk factors affecting hospital stay and hospital costs in open heart surgery for patients> or = 65 years old. Eur J Cardiothorac Surg. 1997 ;11:1133– 1140.

34.

Heller AR, Fischer S, Rossel T, et al. Impact of n-3 fatty acid supplemented parenteral nutrition on haemostasis patterns after major abdominal surgery. Br J Nutr. 2002 ;87(suppl 1):S95– S101.

35.

Vanschoonbeek K, de Maat MPM, Heemskerk JWM. Fish oil consumption and reduction of arterial disease. J Nutr. 2003 ;133:657– 660.

36.

Kendall SJ, Weir J, Aspinall R, Henderson D, Rosson J. Erythrocyte transfusion causes immunosuppression after total hip replacement. Clin Orthop. 2000;145– 155.

37.

Shorr AF, Jackson WL, Kelly KM, Fu M, Kollef MH. Transfusion practice and blood stream infections in critically ill patients.Chest. 2005;127:1722– 1728.

38.

Gessler P, Pfenninger J, Pfammatter JP, Carrel T, Dahinden C. Inflammatory response of neutrophil granulocytes and monocytes after cardiopulmonary bypass in pediatric cardiac surgery. Intensive Care Med. 2002;28:1786– 1791.

39.

Niessen HWM, Lagrand WK, Visser CA, Meijer CJLM, Hack CE. Upregulation of ICAM-1 on cardiomyocytes in jeopardized human myocardium during infarction. Cardiovasc Res. 1999 ;41:603– 610.

40.

Bozzetti F, Braga M, Gianotti L, Gavazzi C, Mariani L. Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial.Lancet. 2001;358:1487– 1492.

41.

Setty S, Tune JD, Downey HF. Nitric oxide contributes to oxygen demand-supply balance in hypoperfused right ventricle. Cardiovasc Res. 2004;64:431– 436.

42.

Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol Heart Circ Physiol. 1992 ;262:H611– H615.

43.

Braga M, Gianotti L, Cestari A, et al. Gut function and immune and inflammatory responses in patients perioperatively fed with supplemented enteral formulas. Arch Surg. 1996 ;131:1257– 1264.